{"id":"anti-cd38-monoclonal-antibody","phase":"phase_1","safety":{"commonSideEffects":[{"rate":"30%","effect":"Fatigue"},{"rate":"20%","effect":"Nausea"},{"rate":"15%","effect":"Diarrhea"}]},"status":"active","trials":["NCT07090954","NCT06571864"],"aliases":[],"patents":[],"pricing":[],"timeline":[],"aiSummary":"Monoclonal antibody targeting CD38 Used for Multiple myeloma.","brandName":"Anti-CD38 Monoclonal Antibody","companyId":"genrix-shanghai-biopharmaceutical-co-ltd","mechanism":{"_ai_source":"groq-llama-8b","explanation":"CD38 is a transmembrane glycoprotein involved in the regulation of cell adhesion, migration, and signaling. The anti-CD38 monoclonal antibody is designed to bind to CD38 and modulate its activity.","oneSentence":"Monoclonal antibody targeting CD38","_ai_confidence":"medium"},"commercial":null,"companyName":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","competitors":[],"genericName":"Anti-CD38 Monoclonal Antibody","indications":{"approved":[{"name":"Multiple myeloma"}]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}